First Fast PCR Saliva COVID-19 Tests for Point of Care Conducted in Canada - Read Press Release

Sal6830 Landing Page

Introducing the world’s first saliva-based PCR test

Songbird was the first company in Canada to offer point of care rapid testing during the height of the pandemic. Now, Songbird is introducing Sal6830, the world’s first saliva-based PCR test, to its range of authorized DNA/RNA-identification technologies.

Authorized by Health Canada and the FDA for emergency use, Sal6830 combines the speed and convenience of an antigen test with the accuracy of a PCR test.

Find out if Sal6830 is right for your workplace.


Easy-to-collect saliva
sample is non-invasive, making testing more comfortable than nasal swabs

Results in under 30 minutes

Returns results in 27

Anytime, anywhere

PCR testing where and when it is needed for real-time decision making.

High-performance PCR

FDA authorized* point-of-care technology captures intact virus, an important
indicator of infection.

Why Saliva?

Painless sampling Eliminates the need for uncomfortable swab testing.

Self-collected samples Limits worker exposure, decreasing the risk of viral transmission..

Resistant to global supply chain shortages Does not require any additional materials to carry out a test. Proudly developed and manufactured in the United States.


Authorized for emergency use by Health Canada

Authorized for emergency use by the FDA under an EUA for use by authorized laboratories or under a CIA waiver.

Developed with the support from the National Institutes of Health (NIH), Rapid Acceleration of Diagnostics (RADx) initiative.

Saliva-based PCR tests are ideal for congregate work settings

  • Companies requiring employees to come back into the physical office.
  • Remote mining operations where PCR testing is not readily available.
  • Manufacturing facilities where physical distancing is not possible and avoiding downtime is critical.
  • Sports tournaments where players come in close contact over the course of a few days.